Cargando…
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
Cancer vaccines may be harnessed to incite immunity against poorly immunogenic tumors, however they have failed in therapeutic settings. Poor antigenicity coupled with systemic and intratumoral immune suppression have been significant drawbacks. RNA encoding for tumor associated or specific epitopes...
Autores principales: | Sayour, Elias J., Mendez-Gomez, Hector R., Mitchell, Duane A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213933/ https://www.ncbi.nlm.nih.gov/pubmed/30249040 http://dx.doi.org/10.3390/ijms19102890 |
Ejemplares similares
-
Direct imaging of RNA loaded lipid-nanoparticles’ self assembly and cellular expression for cancer immunotherapy and RNA-based vaccines
por: Ashbrook, Jewel, et al.
Publicado: (2022) -
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
por: Sayour, Elias J, et al.
Publicado: (2015) -
Immunotherapy for Pediatric Brain Tumors
por: Sayour, Elias J., et al.
Publicado: (2017) -
Emerging trends in immunotherapy for pediatric sarcomas
por: Dyson, Kyle A., et al.
Publicado: (2019) -
Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
por: Sayour, Elias J., et al.
Publicado: (2017)